Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02379247
Title BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Kansas
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Kansas Cancer Center Kansas City Kansas 66205 United States Details
University of Kansas Cancer Center - Overland Park Overland Park Kansas 66210 United States Details
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field